Summary

Report Scope:

The current report offers a detailed picture of the AI medical diagnostics market.

This report highlights the current and future market potential for AI medical diagnostics and provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities, and trends in the market. The report also covers market projections through 2026, as well as key market players.

This report discusses the AI medical diagnostics market and its various resources. It covers the overall AI medical diagnostics market including hardware, software and analytics, and services. The report further analyzes the market based on application, providing an analysis of oncology, cardiology, neurology, orthopedic and others. In addition, the report also analyses various modalities of diagnostics imaging including MRI, CT scans, ultrasounds, X-rays and others (ECG, EEG, etc.). Furthermore, a complete regional analysis of the market is also studied in the report.

Based on geography, the market has been segmented into North America, Europe, Asia-Pacific and the Rest of the World (which includes Latin America, and the Middle East and Africa). Detailed analyses of major countries (the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China and India) are covered in regional segments. For market estimates, data has been provided for 2020 as the base year, with forecasts for 2021 through 2026. Estimated values are based on product manufacturers’ total revenues. Projected and forecasted revenue values are in constant U.S. dollars that have not been adjusted for inflation.

Report Includes:

- 68 data tables and 67 additional tables
- A brief general outlook of the global market for artificial intelligence (AI) in medical diagnostics
- Analyses of the global market trends, with historic data from 2019 and 2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through 2026
- Evaluation and forecast the global AI medical diagnostics market size, and corresponding market share analysis by component, medical specialty application area, end-user, treatment modality, and geographic region
- Technology assessment of the key drivers, restraints and opportunities that will shape the market for AI medical diagnostics over the next five years (2021 to 2026)
- Country specific data and market value analysis for the U.S., Canada, France, Germany, U.K., Italy, Spain, China, India, Japan and other emerging economies
- Identification of key artificial intelligence technologies and products with the greatest commercial potential, and relevant applications of various AI tools in medical diagnosis, breakthrough therapies and patient health management
- Highlights of the COVID-19 impact on the global AI medical diagnostics market as well as the overall MedTech industry
- Insight into recent industry structure, current competitive scenario, R&D activities, regulatory and legislative issues, and product launch strategies currently focused on AI technologies
- Patent activity and review of patent grants for AI medical diagnostics across each major category
- Understanding of the start-up ecosystem and competitor dashboard for key market participants in global AI medical diagnostics market
- Descriptive company profiles of the leading market players, including Canon Medical System Corp., GE Healthcare, Intel, IBM Corp., Nano-X Imaging Ltd., Siemens Healthcare GmbH, and Subtle Medical, Inc.

ページTOPに戻る

Table of Contents

Table of Contents
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
Introduction to Artificial Intelligence
Understanding Artificial Intelligence in Healthcare
Artificial Intelligence in Healthcare Evolution and Transition
Defining Artificial Intelligence in Medical Diagnostics
Disease Detection and Diagnostics
Industry Structure
Data Warehouse
Artificial Intelligence (AI) Analysis
Software Development
List of FDA-Approved AI and Machine Learning-Enabled Medical Devices/Diagnostics Devices and Algorithms
AI and Machine Learning-Enabled Medical Devices/Radiology and Other Imaging Modalities
Artificial Intelligence and Machine Learning (AI/ML) Algorithms
Chapter 4 Market Dynamics
Drivers
Investment in AI Health Sector
Increasing Strategic Moves by Market Players
Rising Incidence of Chronic Diseases
Restraints and Challenges
Reluctance Among Medical Practitioners to Adopt AI-Based Technologies
Ambiguous Regulatory Guidelines for Medical Software
Challenge To Maintain Data Security
Opportunities
Integration of Software with Artificial Intelligence
Untapped Potential in Emerging Markets
Chapter 5 Impact of COVID-19 on the AI Medical Diagnostics Market
Introduction
Regulatory Delays, Clinical Trials and Product Launches
Supply Chain Disruptions
Impact on MedTech
Impact on AI Medical Diagnostics
Home-Based Pathology
Chapter 6 Global Market for AI Medical Diagnostics by Component
Software
Services
Hardware
Chapter 7 Global Market for AI Medical Diagnostics by Medical Specialty Application Area
Oncology
Cardiology
Neurology
Orthopedics
Others
Chapter 8 Global Market for AI Medical Diagnostics by End User
Hospitals and Clinics
Diagnostic Imaging Centers and Diagnostic Laboratories
Chapter 9 Global Market for AI Medical Diagnostics by Modality
MRI
CT Scans
Common Applications of CT Scans
Application of CT in Pediatric Patients
Benefits
Ultrasound
X-Rays
Advantages of X-Ray Machines
Others
Chapter 10 Global Market for AI Medical Diagnostics by Region
North America
United States
Canada
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Rest of Asia-Pacific
Rest of the World
Chapter 11 Regulatory Framework
Regulatory Framework
American Diabetes Association's Standards of Medical Care in Diabetes
ATA Guidelines for Artificial Intelligence (AI)
Indian AI Guidelines, Strategy and Standards
Chapter 12 Patent Review
Introduction
Patent Review
Companies Granted Patents in AI Medical Diagnostics
Patent Review by Geography
Chapter 13 Start-up Ecosystem
Introduction
Chapter 14 Competitive Landscape Analysis
Primary Strategies: Partnerships, Collaborations, Agreements and Contracts
FDA/CE Mark/EU Approval: Secondary Strategy
Review of Company Strategies Used
Chapter 15 Company Profiles
AIDOC MEDICAL LTD.
ARTERYS INC.
BEHOLD.AI TECHNOLOGIES LTD.
BUTTERFLY NETWORK
CANON MEDICAL SYSTEM CORP.
CAPTION HEALTH
DEEPMIND TECHNOLOGIES LTD.
DIGITAL DIAGNOSTICS
ENLITIC INC.
FUJIFILM HOLDING CORP.
GE HEALTHCARE
HEURON CO., LTD.
IMAGEN TECHNOLOGIES
INTERNATIONAL BUSINESS MACHINES CORP. (IBM)
ICARBONX
INTEL CORP.
MEDTRONIC PLC
MICROSOFT CORP.
NANO-X IMAGING LTD.
NVIDIA
PHILIPS HEALTHCARE
QURE.AI
ROCHE HOLDING AG
SAMSUNG ELECTRONICS INC.
SIEMENS HEALTHCARE
SUBTLE MEDICAL, INC.
SYNAPSICA
XILINX, INC.